Literature DB >> 20420514

Fatalities associated with the 2009 H1N1 influenza A virus in New York city.

Ellen H Lee1, Charles Wu, Elsie U Lee, Alaina Stoute, Heather Hanson, Heather A Cook, Beth Nivin, Annie D Fine, Bonnie D Kerker, Scott A Harper, Marcelle C Layton, Sharon Balter.   

Abstract

BACKGROUND. When the 2009 H1N1 influenza A virus emerged in the United States, epidemiologic and clinical information about severe and fatal cases was limited. We report the first 47 fatal cases of 2009 H1N1 influenza in New York City. METHODS. The New York City Department of Health and Mental Hygiene conducted enhanced surveillance for hospitalizations and deaths associated with 2009 H1N1 influenza A virus. We collected basic demographic and clinical information for all patients who died and compared abstracted data from medical records for a sample of hospitalized patients who died and hospitalized patients who survived. RESULTS. From 24 April through 1 July 2009, 47 confirmed fatal cases of 2009 H1N1 influenza were reported to the New York City Department of Health and Mental Hygiene. Most decedents (60%) were ages 18-49 years, and only 4% were aged 65 years. Many (79%) had underlying risk conditions for severe seasonal influenza, and 58% were obese according to their body mass index. Thirteen (28%) had evidence of invasive bacterial coinfection. Approximately 50% of the decedents had developed acute respiratory distress syndrome. Among all hospitalized patients, decedents had presented for hospitalization later (median, 3 vs 2 days after illness onset; P < .05) and received oseltamivir later (median, 6.5 vs 3 days; P < .01) than surviving patients. Hospitalized patients who died were less likely to have received oseltamivir within 2 days of hospitalization than hospitalized patients who survived (61% vs 96%; P < .01). CONCLUSIONS. With community-wide transmission of 2009 H1N1 influenza A virus, timely medical care and antiviral therapy should be considered for patients with severe influenza-like illness or with underlying risk conditions for complications from influenza.

Entities:  

Mesh:

Year:  2010        PMID: 20420514     DOI: 10.1086/652446

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  50 in total

1.  Impaired wound healing predisposes obese mice to severe influenza virus infection.

Authors:  Kevin B O'Brien; Peter Vogel; Susu Duan; Elena A Govorkova; Richard J Webby; Jonathan A McCullers; Stacey Schultz-Cherry
Journal:  J Infect Dis       Date:  2011-12-05       Impact factor: 5.226

Review 2.  Influenza susceptibility, severity, and shedding in HIV-infected adults: a review of the literature.

Authors:  Anandi N Sheth; Keri N Althoff; John T Brooks
Journal:  Clin Infect Dis       Date:  2011-01-15       Impact factor: 9.079

3.  Surveillance of illness associated with pandemic (H1N1) 2009 virus infection among adults using a global clinical site network approach: the INSIGHT FLU 002 and FLU 003 studies.

Authors:  Dominic E Dwyer
Journal:  Vaccine       Date:  2011-07-22       Impact factor: 3.641

Review 4.  Impact of H1N1 on socially disadvantaged populations: summary of a systematic review.

Authors:  Andrea C Tricco; Erin Lillie; Charlene Soobiah; Laure Perrier; Sharon E Straus
Journal:  Influenza Other Respir Viruses       Date:  2013-09       Impact factor: 4.380

5.  Improving the evidence base for decision making during a pandemic: the example of 2009 influenza A/H1N1.

Authors:  Marc Lipsitch; Lyn Finelli; Richard T Heffernan; Gabriel M Leung; Stephen C Redd
Journal:  Biosecur Bioterror       Date:  2011-06

6.  Influenza A (H1N1) 2009 monovalent and seasonal influenza vaccination among adults 25 to 64 years of age with high-risk conditions--United States, 2010.

Authors:  Peng-jun Lu; Amparo Gonzalez-Feliciano; Helen Ding; Leah N Bryan; David Yankey; Elizabeth A Monsell; Stacie M Greby; Gary L Euler
Journal:  Am J Infect Control       Date:  2013-02-15       Impact factor: 2.918

7.  Epidemiology of influenza A (H1N1)pdm09-associated deaths in the United States, September-October 2009.

Authors:  Joanna Regan; Ashley Fowlkes; Matthew Biggerstaff; Michael A Jhung; Jacqueline Gindler; Erin Kennedy; Victoria Fields; Lyn Finelli
Journal:  Influenza Other Respir Viruses       Date:  2012-07-16       Impact factor: 4.380

Review 8.  Neuraminidase inhibitors for influenza: a review and public health perspective in the aftermath of the 2009 pandemic.

Authors:  Charles R Beck; Rachel Sokal; Nachiappan Arunachalam; Richard Puleston; Anna Cichowska; Anthony Kessel; Maria Zambon; Jonathan S Nguyen-Van-Tam
Journal:  Influenza Other Respir Viruses       Date:  2013-01       Impact factor: 4.380

Review 9.  Influenza and HIV: lessons from the 2009 H1N1 influenza pandemic.

Authors:  Anandi N Sheth; Pragna Patel; Philip J Peters
Journal:  Curr HIV/AIDS Rep       Date:  2011-09       Impact factor: 5.071

Review 10.  Review on the impact of pregnancy and obesity on influenza virus infection.

Authors:  Erik A Karlsson; Glendie Marcelin; Richard J Webby; Stacey Schultz-Cherry
Journal:  Influenza Other Respir Viruses       Date:  2012-02-15       Impact factor: 4.380

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.